LANTHEUS HOLDINGS INC (LNTH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LNTH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LNTH | Member; Director | 78 | ["regulatory and legal background", "extensive experience in the pharmaceutical industry", "Current President, B-Henry & Associates", "Former Worldwide Vice President for Regulatory Affairs, Johnson & Johnson", "Former National Director for Regulatory & Capital Markets Consulting, Deloitte & Touche", "Various former roles at U.S. Food and Drug Administration", "Former President & Board Chair, Drug Information Association", "Former Director, scPharmaceuticals", "Education: Pharmacy Degree, Howard University\u2019s College of Pharmacy", "Education: J.D., Catholic University\u2019s Columbus School of Law"] | ["Member", "Nominating and Corporate Governance Committee", "Science and Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Director since 2022 Independent 78 years old Committees: Nominating and Corporate Governance Committee Science and Technology Committee Specific Expertise: Ms. Baylor-Henry was chosen as a Director because of her regulatory and legal background and extensive experience in the pharmaceutical industry. Career Highlights: Current President, B-Henry & Associates, a consulting firm focused on providing regulatory and compliance strategy services to life sciences companies (2015 present) Former Worldwide Vice President for Regulatory Affairs, Johnson & Johnson s Medical Devices & Diagnostics business where Ms. Baylor-Henry was directly responsible for coordinating the regulatory strategy for the approval of a wide portfolio of products globally Former National Director for Regulatory & Capital Markets Consulting, Deloitte & Touche Various former roles at U.S. Food and Drug Administration (the FDA ), most notably, FDA s National Health Fraud Coordinator and, within the Center for Drugs, as the Director of the Division of Drug Marketing, Advertising, and Communications (1991-1999) Former President & Board Chair, Drug Information Association and the Food and Drug Law Institute Other Public Company Boards: Current Director, Apyx Medical Corp Former Director, scPharmaceuticals Other Boards: Howard University Dress for Success Boston Education: Pharmacy Degree, Howard University s College of Pharmacy J.D., Catholic University s Columbus School of Law